|
| Entrez Id: |
2177 |
| Gene Symbol: |
FANCD2 |
FANCD2
|
0.620 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
2177 |
| Gene Symbol: |
FANCD2 |
FANCD2
|
0.620 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
641 |
| Gene Symbol: |
BLM |
BLM
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
|
| Entrez Id: |
2176 |
| Gene Symbol: |
FANCC |
FANCC
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Discussing and managing hematologic germ line variants.
|
27881370 |
2016 |
|
| Entrez Id: |
2176 |
| Gene Symbol: |
FANCC |
FANCC
|
0.610 |
GeneticVariation
|
disease |
LHGDN |
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
|
18607065 |
2008 |
|
| Entrez Id: |
641 |
| Gene Symbol: |
BLM |
BLM
|
0.610 |
Biomarker
|
disease |
LHGDN |
BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin.
|
15750625 |
2005 |
|
| Entrez Id: |
2176 |
| Gene Symbol: |
FANCC |
FANCC
|
0.610 |
GenomicAlterations
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2176 |
| Gene Symbol: |
FANCC |
FANCC
|
0.610 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
641 |
| Gene Symbol: |
BLM |
BLM
|
0.610 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
2176 |
| Gene Symbol: |
FANCC |
FANCC
|
0.610 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
641 |
| Gene Symbol: |
BLM |
BLM
|
0.610 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2175 |
| Gene Symbol: |
FANCA |
FANCA
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
|
| Entrez Id: |
2178 |
| Gene Symbol: |
FANCE |
FANCE
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
|
| Entrez Id: |
2189 |
| Gene Symbol: |
FANCG |
FANCG
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
|
| Entrez Id: |
2175 |
| Gene Symbol: |
FANCA |
FANCA
|
0.600 |
GenomicAlterations
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2175 |
| Gene Symbol: |
FANCA |
FANCA
|
0.600 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
2178 |
| Gene Symbol: |
FANCE |
FANCE
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2178 |
| Gene Symbol: |
FANCE |
FANCE
|
0.600 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
2175 |
| Gene Symbol: |
FANCA |
FANCA
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2189 |
| Gene Symbol: |
FANCG |
FANCG
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
2189 |
| Gene Symbol: |
FANCG |
FANCG
|
0.600 |
Biomarker
|
disease |
HPO |
|
|
|
|
| Entrez Id: |
2188 |
| Gene Symbol: |
FANCF |
FANCF
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
|
| Entrez Id: |
2188 |
| Gene Symbol: |
FANCF |
FANCF
|
0.510 |
Biomarker
|
disease |
BEFREE |
Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
|
25647473 |
2015 |
|
| Entrez Id: |
2188 |
| Gene Symbol: |
FANCF |
FANCF
|
0.510 |
CausalMutation
|
disease |
CGI |
|
|
|
|
| Entrez Id: |
83990 |
| Gene Symbol: |
BRIP1 |
BRIP1
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |